Breaking

Top Salvadoran ex-military officers sentenced for wartime killing of Dutch journalists
‘Death and hunger’: Videos, expert analysis and witnesses point to Israeli gunfire in Gaza aid site shooting
Argentina’s president denies new intelligence plan could enable surveillance of journalists and politicians
US vetoes UN Security Council resolution demanding Gaza ceasefire
Germany’s straight-talking new leader is meeting with Trump for the first time. Here’s why it matters
These clever birds can open trash cans and drink from water fountains
One in three Australian men say they have committed intimate partner violence, study reveals
Bodies of two Israeli-American hostages recovered from Gaza in joint military operation

World News
Science
Investing
Business
Search for:

Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

CHARBONE Hydrogen Executed a USD 50MM Financing to Accelerate its Hydrogen’s North American Expansion Facilitated by US Capital Global

Wildfires Slash Canadian Oil Output by 7 Percent

Crypto Market Recap: Truth Social Moves to Launch Spot Bitcoin ETF, Reserve Act Near?

Fill Out & Get More Relevant News

Your name

Your email

Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.
Categories
- Business (1,115)
- Investing (2,668)
- Science (573)
- World News (3,261)

Disclaimer: digitaltradecenter.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest Posts
- Privacy Policy
- Terms & Conditions

Copyright © 2025 digitaltradecenter.com | All Rights Reserved

Top

World News
Science
Investing
Business

Type above and press Enter to search. Press Esc to cancel.